pancreatitis with disconnected duct syndrome (5; 6%), adenocarcinoma (3; 4%) and other (10; 11%). In patients with adenocarcinoma, the diagnosis was made postoperatively and completion distal pancreatectomy was done few weeks later. The mean operative time was 183 (90-285), the mean blood loss 107 (0-800), one transfusion (1%), and one conversion (1%) in the early experience. The pancreas was hard in 37 patients (46%). No 90 days mortality and the overall morbidity was observed in 58 patients (72%) including grade B/C pancreatic fistula (21; 26%), bleeding (10; 12%) which was severe in 5 (6%), drained collection (2; 3%), delayed gastric emptying (2; 3%), reintervention (5; 6%), and pulmonary complications (3; 4%). the mean hospital stay was 22 days (5-54) with readmission in 2 (2%). The mean number of harvested lymph nodes was 3 (0-19) including 18 (22%) patients with zero harvested lymph nodes. Lymph nodes were only invaded in patients who turned to have adenocarcinoma. Resection was R0 in 71 (88%) patients. Conclusion: The applicability of laparoscopic central pancreatectomy is high and the morbidity is acceptable. There is a real advantage on the preservation of the pancreatic function and abdominal wall in these young patients with no malignancy.
Conclusion: Octogenarians with PDAC-NBT have significant differences in surgical and medical treatment metrics, including lower rates of R0 resection and adjuvant therapy. Despite this, there were no overall differences in perioperative morbidity, mortality, or survival. These data suggest that resection should be pursued in the appropriately selected octogenarian as outcomes are not associated with age-related clinicopathologic factors.Background: Temporary inactivation on the liver transplant waitlist or "Status7" is a transplant center dependent practice. Patients can be inactivated or made Status7 for a variety of reasons including: temporarily too sick, temporarily too well, insurance issues, incomplete work-up, noncompliance and substance abuse, candidate choice, high BMI, and because they cannot be contacted. The criteria to inactivate patients is dependent on individual centers. While Status7, patients are not eligible for liver transplantation. Outcomes of patients following Status7 have not been reported. Methods: All patients removed from a single center's waitlist from 2005e2016 were retrospectively reviewed. Patients were removed from the waitlist and transplanted or removed prior to transplant. Data collected included: demographic factors, reason for temporary inactivation and waitlist removal, number of times and length of time of inactivation on the waitlist, MELD score, and organ and patient survival after transplant. Univariate and survival analyses were performed. Results: Of 1567 patients removed (1075 transplanted; 492 not-transplanted), 31.0% were Status7 at least once. Of the Status7 patients, only 25.1% (n = 122) were transplanted, whereas 88.2% (n = 953) patients never made Status7 were transplanted (p 0.09). Overall, a higher proportion of women than men were not transplanted (36.5% vs 28.5%) (p = 0.002). However, a similar proportion of women and men were Status7 at least once (32.4% vs 29.9%) for similar reasons (52.6% vs 51.3% "too sick"). A significantly lower proportion of women were transplanted after Status7 (17.7% vs. 29.6%) (p = 0.004) (Table). Conclusion: Overall, a history of being Status7 was associated with a higher likelihood of being removed from the waitlist without transplantation. However, patients who were transplanted after a history of temporary inactivation for being "too sick", there was similar patient and organ survival. Women were statistically less likely to ultimately reach transplant despite a similar proportion women and men being made Status7 while on the waitlist. Women were significantly less likely to be transplanted after an episode of temporary inactivation on the waitlist. Investigation is needed to identify why less women recover from temporary inactivation than men.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.